Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Kobayashi T, Iwama S, Sugiyama E, Koyama S, Izuchi T, Suzuki K, Murase T, Ando M, Inaba H, Izumi H, Goto K, Handa T, Onoue T, Miyata T, Sugiyama M, Hagiwara D, Suga H, Banno R, Akatsuka Y, Nishikawa H, Arima H, Nagoya University related Hospitals group

Open source

DOI: 10.1158/2326-6066.cir-25-0693
Published: 2026 Apr 2
Container: Cancer immunology research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2326-6066.cir-25-0693,
  title = {Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.},
  author = {Kobayashi T and Iwama S and Sugiyama E and Koyama S and Izuchi T and Suzuki K and Murase T and Ando M and Inaba H and Izumi H and Goto K and Handa T and Onoue T and Miyata T and Sugiyama M and Hagiwara D and Suga H and Banno R and Akatsuka Y and Nishikawa H and Arima H and Nagoya University related Hospitals group},
  year = {2026},
  journal = {Cancer immunology research},
  doi = {10.1158/2326-6066.cir-25-0693},
  url = {https://doi.org/10.1158/2326-6066.cir-25-0693}
}

RIS

TY  - JOUR
TI  - Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.
AU  - Kobayashi T
AU  - Iwama S
AU  - Sugiyama E
AU  - Koyama S
AU  - Izuchi T
AU  - Suzuki K
AU  - Murase T
AU  - Ando M
AU  - Inaba H
AU  - Izumi H
AU  - Goto K
AU  - Handa T
AU  - Onoue T
AU  - Miyata T
AU  - Sugiyama M
AU  - Hagiwara D
AU  - Suga H
AU  - Banno R
AU  - Akatsuka Y
AU  - Nishikawa H
AU  - Arima H
AU  - Nagoya University related Hospitals group
PY  - 2026
JO  - Cancer immunology research
DO  - 10.1158/2326-6066.cir-25-0693
UR  - https://doi.org/10.1158/2326-6066.cir-25-0693
ER  -

APA

T, K., S, I., E, S., S, K., T, I., K, S., T, M., M, A., H, I., H, I., K, G., T, H., T, O., T, M., M, S., D, H., H, S., R, B., Y, A., H, N., H, A., & group, N. U. R. H. (2026). Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.. Cancer immunology research. https://doi.org/10.1158/2326-6066.cir-25-0693

Source records

pubmed · retrieved 2026-11-10T15:12:03.412Z